{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:50:47Z","timestamp":1770490247089,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["148908"],"award-info":[{"award-number":["148908"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Ethics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Little is known about volunteers from Northern research settings who participate in vaccine trials of highly infectious diseases with no approved treatments. This article explores the motivations of HIV immunocompromised study participants in Canada who volunteered in a Phase II clinical trial that evaluated the safety and immunogenicity of an Ebola vaccine candidate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Observation at the clinical study site and semi-structured interviews employing situational and discursive analysis were conducted with clinical trial participants and staff over one year. Interviews were recorded, transcribed and analysed using critical qualitative interpretivist thematic analytical techniques. Patterns were identified, clustered and sorted to generate distinct and comprehensive themes. We then reassembled events and contexts from the study participants\u2019 stories to develop two ideal portraits based on \"composite characters\" based on study participants features. These provide ethnographically rich details of participants\u2019 meaningful social worlds while protecting individual identities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ten of the 14 clinical trial participants, and 3 study staff were interviewed. Participant demographics and socio-economic profiles expressed limited contextual diversity. Half were men who have sex with men, half were former injection drug users experiencing homelessness, one was female, none were racialized minorities and there were no people from HIV endemic countries. Fully 90% had previous involvement in other clinical studies. Their stories point to particular socio-economic situations that motivated their participation as clinical labor through trial participation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings support Fisher\u2019s argument of \u201cstructural coercion\u201d in clinical trial recruitment of vulnerable individuals experiencing precarious living conditions. Clinical trials should provide more detail of the structural socio-economic conditions and healthcare needs which lie \u201cunder consent\u201d of study participants. Going well beyond an overly convenient narrative of altruism, ethical deliberation frameworks need to sufficiently address the structural conditions of clinical trials. We offer concrete possibilities for this and acknowledge that further research and clinical data should be made available underlying study participant contexts with regards to recruitment and participation in resource poor settings, in both the South and the North.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12910-021-00606-6","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T10:03:40Z","timestamp":1617962620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Under consent: participation of people with HIV in an Ebola vaccine trial in Canada"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7441-0633","authenticated-orcid":false,"given":"Pierre-Marie","family":"David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Mathiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oumy","family":"Thiongane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice E.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"issue":"2","key":"606_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1525\/ae.2005.32.2.183","volume":"32","author":"A Petryna","year":"2005","unstructured":"Petryna A. Ethical variability: drug development and globalizing clinical trials. Am Ethnol. 2005;32(2):183\u201397.","journal-title":"Am Ethnol"},{"key":"606_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1215\/9780822393245","volume-title":"The professional guinea pig: big pharma and the risky world of human subjects","author":"R Abadie","year":"2010","unstructured":"Abadie R. The professional guinea pig: big pharma and the risky world of human subjects. Durham: Duke University Press; 2010. p. 200."},{"key":"606_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2307\/j.ctv1168b2w","volume-title":"Clinical labor: tissue donors and research subjects in the global bioeconomy","author":"M Cooper","year":"2014","unstructured":"Cooper M, Waldby C. Clinical labor: tissue donors and research subjects in the global bioeconomy. Durham: Duke University Press; 2014. p. 296."},{"key":"606_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s13063-015-1110-6","volume":"16","author":"NH Gobat","year":"2015","unstructured":"Gobat NH, Gal M, Francis NA, Hood K, Watkins A, Turner J, et al. Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi\/pandemic research preparedness. Trials. 2015;16:591.","journal-title":"Trials"},{"issue":"4","key":"606_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/09581596.2019.1597966","volume":"29","author":"JE Graham","year":"2019","unstructured":"Graham JE. Ebola vaccine innovation: a case study of pseudoscapes in global health. Crit Public Health. 2019;29(4):401\u201312.","journal-title":"Crit Public Health"},{"key":"606_CR6","unstructured":"National Academies of Sciences, Engineering, and Medicine. Integrating Clinical Research into Epidemic Response: The Ebola Experience. Washington DC: The National Academies Press; 2017. 336. p."},{"key":"606_CR7","doi-asserted-by":"publisher","first-page":"g4997","DOI":"10.1136\/bmj.g4997","volume":"349","author":"S Arie","year":"2014","unstructured":"Arie S. Ebola: an opportunity for a clinical trial? BMJ. 2014;349:g4997.","journal-title":"BMJ"},{"issue":"14","key":"606_CR8","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1056\/NEJMp1902682","volume":"380","author":"V-K Nguyen","year":"2019","unstructured":"Nguyen V-K. An epidemic of suspicion\u2014ebola and violence in the DRC. N Engl J Med. 2019;380(14):1298\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"606_CR9","doi-asserted-by":"publisher","first-page":"e000990","DOI":"10.1136\/bmjgh-2018-000990","volume":"3","author":"JE Graham","year":"2018","unstructured":"Graham JE, Lees S, Le Marcis F, Faye SL, Lorway RR, Ronse M, et al. Prepared for the \u2018unexpected\u2019? Lessons from the 2014\u20132016 Ebola epidemic in West Africa on integrating emergent theory designs into outbreak response. BMJ Glob Health. 2018;3(4):e000990.","journal-title":"BMJ Glob Health."},{"issue":"1","key":"606_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12910-016-0094-4","volume":"17","author":"MO Folayan","year":"2016","unstructured":"Folayan MO, Yakubu A, Haire B, Peterson K. Ebola vaccine development plan: ethics, concerns and proposed measures. BMC Med Ethics. 2016;17(1):10.","journal-title":"BMC Med Ethics"},{"issue":"2","key":"606_CR11","first-page":"76","volume":"1","author":"M De Crop","year":"2016","unstructured":"De Crop M, Delamou A, Griensven JV, Ravinetto R. Multiple ethical review in North-South collaborative research: the experience of the Ebola-Tx trial in Guinea. Indian J Med Ethics. 2016;1(2):76\u201382.","journal-title":"Indian J Med Ethics"},{"issue":"11","key":"606_CR12","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S1473-3099(15)00375-8","volume":"15","author":"PW Horby","year":"2015","unstructured":"Horby PW, Endtz H, Muyembe-Tamfum J-J, van Griensven J, Gevao S, Goossens H, et al. Ebola: Europe-Africa research collaborations. Lancet Infect Dis. 2015;15(11):1258\u20139.","journal-title":"Lancet Infect Dis"},{"key":"606_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.coviro.2016.03.008","volume":"17","author":"AM Henao-Restrepo","year":"2016","unstructured":"Henao-Restrepo AM, Preziosi M-P, Wood D, Moorthy V, Kieny MP. On a path to accelerate access to Ebola vaccines: the WHO\u2019s research and development efforts during the 2014\u20132016 Ebola epidemic in West Africa. Curr Opin Virol. 2016;17:138\u201344.","journal-title":"Curr Opin Virol"},{"issue":"1","key":"606_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s13063-019-3487-0","volume":"20","author":"E Lhomme","year":"2019","unstructured":"Lhomme E, Modet C, Augier A, Faye S, Dabakuyo-Yonli TS, Levy-Marchal C, et al. Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context. Trials. 2019;20(1):422.","journal-title":"Trials"},{"issue":"17","key":"606_CR15","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","volume":"374","author":"ST Agnandji","year":"2016","unstructured":"Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, et al. Phase 1 trials of rVSV Ebola Vaccine in Africa and Europe. N Engl J Med. 2016;374(17):1647\u201360.","journal-title":"N Engl J Med"},{"issue":"4","key":"606_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1414216","volume":"376","author":"JA Regules","year":"2017","unstructured":"Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, Hu Z, et al. A recombinant vesicular stomatitis virus Ebola vaccine. N Engl J Med. 2017;376(4):330\u201341.","journal-title":"N Engl J Med."},{"issue":"24","key":"606_CR17","doi-asserted-by":"publisher","first-page":"E819","DOI":"10.1503\/cmaj.170074","volume":"189","author":"MS ElSherif","year":"2017","unstructured":"ElSherif MS, Brown C, MacKinnon-Cameron D, Li L, Racine T, Alimonti J, et al. Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial. CMAJ Can Med Assoc J. 2017;189(24):E819\u201327.","journal-title":"CMAJ Can Med Assoc J"},{"issue":"2","key":"606_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.vaccine.2018.11.014","volume":"37","author":"A Cattapan","year":"2019","unstructured":"Cattapan A, Browne K, Halperin DM, Di Castri A, Fullsack P, Graham J, et al. Motivation for participating in phase 1 vaccine trials: comparison of an influenza and an Ebola randomized controlled trial. Vaccine. 2019;37(2):289\u201395.","journal-title":"Vaccine"},{"key":"606_CR19","first-page":"508","volume-title":"Evidence, ethos and experiment the anthropology and history of medical research in Africa","author":"PW Geissler","year":"2017","unstructured":"Geissler PW, Molyneux C. Evidence, ethos and experiment the anthropology and history of medical research in Africa. New York: Berghahn Books; 2017. p. 508."},{"issue":"245","key":"606_CR20","doi-asserted-by":"publisher","first-page":"112670","DOI":"10.1016\/j.socscimed.2019.112670","volume":"2020","author":"S Mwale","year":"2020","unstructured":"Mwale S. Becoming-with\u2019 a repeat healthy volunteer: Managing and negotiating trust among repeat healthy volunteers in commercial clinical drug trials. Soc Sci Med. 2020;2020(245):112670.","journal-title":"Soc Sci Med"},{"key":"606_CR21","doi-asserted-by":"crossref","unstructured":"Clarke AE. Grounded theory: critiques, debates, and situational analysis. In: The SAGE handbook of social science methodology. London: SAGE Publications Ltd; 2007. p. 423\u201342.","DOI":"10.4135\/9781848607958.n23"},{"key":"606_CR22","first-page":"177","volume-title":"Doing discourse research: an introduction for social scientists","author":"R Keller","year":"2012","unstructured":"Keller R. Doing discourse research: an introduction for social scientists. London: SAGE Publications Ltd; 2012. p. 177."},{"key":"606_CR23","doi-asserted-by":"publisher","unstructured":"Patton MQ. Qualitative research [Internet]. In: Encyclopedia of statistics in behavioral science. Chichester: Wiley; 2005. https:\/\/doi.org\/10.1002\/0470013192.bsa514.","DOI":"10.1002\/0470013192.bsa514"},{"key":"606_CR24","first-page":"282","volume-title":"The private worlds of dying children","author":"M Bluebond-Langner","year":"1980","unstructured":"Bluebond-Langner M. The private worlds of dying children. Princeton: Princeton University Press; 1980. p. 282."},{"key":"606_CR25","first-page":"560","volume-title":"An anthropology of biomedicine","author":"M Lock","year":"2018","unstructured":"Lock M, Nguyen V-K. An anthropology of biomedicine. 2nd ed. Chichester: Wiley; 2018. p. 560.","edition":"2"},{"key":"606_CR26","unstructured":"U.S. Food & Drug Administration. First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response [Internet]. 2019. https:\/\/www.fda.gov\/news-events\/press-announcements\/first-fda-approved-vaccine-prevention-ebola-virus-disease-marking-critical-milestone-public-health."},{"key":"606_CR27","unstructured":"United Nations. Newly licensed vaccine, \u2018milestone in the fight\u2019 against Ebola in Africa, UN health agency [Internet]. UN News. 2020. https:\/\/news.un.org\/en\/story\/2020\/02\/1057461."},{"issue":"4","key":"606_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1353\/ken.2013.0018","volume":"23","author":"JA Fisher","year":"2013","unstructured":"Fisher JA. Expanding the frame of\" Voluntariness\" in informed consent: Structural coercion and the power of social and economic context. Kennedy Inst Ethics J. 2013;23(4):355\u201379.","journal-title":"Kennedy Inst Ethics J"}],"updated-by":[{"DOI":"10.1186\/s12910-021-00629-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000}}],"container-title":["BMC Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12910-021-00606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12910-021-00606-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12910-021-00606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T01:55:25Z","timestamp":1627696525000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedethics.biomedcentral.com\/articles\/10.1186\/s12910-021-00606-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1186\/s12910-021-00606-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12910-021-00629-z","asserted-by":"object"}]},"ISSN":["1472-6939"],"issn-type":[{"value":"1472-6939","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"assertion":[{"value":"10 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12910-021-00629-z","URL":"https:\/\/doi.org\/10.1186\/s12910-021-00629-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this anthropological case study in Montreal was delivered on October 2, 2018 by the Comit\u00e9 d'\u00e9thique de la Recherche of the Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al (CHUM): number CER-CHUM: 18.161.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual data presented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written consent was obtained from study participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"42"}}